Each quarter, ASCO’s experts review the leading journals, including the Journal of Clinical Oncology, to compile the most relevant, practice-changing science in gastrointestinal cancers. Reviews are presented in a didactic slide format, with audio commentary and links to references and resources and will focus on the following areas: translational science, clinical trials, reviews, guidelines, and editorials.
Articles covered in this quarter’s review include:
- Movahedi M, Bishop DT, Macrae F, et al. Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. J Clin Oncol. 2015 Nov 1;33(31):3591-7.
- Park SH, Sohn TS, Lee J, et al. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. J Clin Oncol. 2015 Oct 1;33(28):3130-6.
- Examine the role of adjuvant therapy in D2-resected gastric cancer and the relationship between characteristics of gastric cancer and type of adjuvant therapy (chemotherapy vs. chemoradiation)
- Discuss the role of external factors (obesity, aspirin use) on a hereditary risk background of colorectal cancer
- Apply knowledge learned to enhance the care delivered to patients with gastrointestinal cancers
Continuing Education Credit
1 Credit/Point is available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.
- This course expires on December 16, 2018. Participants must complete all necessary course compenents by this date to receive credit.